Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Quest Diagnostics Inc (DGX)

Quest Diagnostics Inc (DGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 17,088,256
  • Shares Outstanding, K 111,615
  • Annual Sales, $ 9,252 M
  • Annual Income, $ 854,000 K
  • EBIT $ 1,369 M
  • EBITDA $ 1,808 M
  • 60-Month Beta 0.89
  • Price/Sales 1.83
  • Price/Cash Flow 11.89
  • Price/Book 2.47

Options Overview Details

View History
  • Implied Volatility 21.23% ( +0.10%)
  • Historical Volatility 19.02%
  • IV Percentile 67%
  • IV Rank 42.08%
  • IV High 28.33% on 08/05/24
  • IV Low 16.08% on 12/04/24
  • Put/Call Vol Ratio 0.15
  • Today's Volume 856
  • Volume Avg (30-Day) 302
  • Put/Call OI Ratio 0.44
  • Today's Open Interest 8,699
  • Open Int (30-Day) 8,341

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 16 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate 2.19
  • Number of Estimates 10
  • High Estimate 2.20
  • Low Estimate 2.15
  • Prior Year 2.15
  • Growth Rate Est. (year over year) +1.86%

Price Performance

See More
Period Period Low Period High Performance
1-Month
149.07 +2.70%
on 12/19/24
165.32 -7.39%
on 11/25/24
-8.22 (-5.10%)
since 11/20/24
3-Month
146.17 +4.74%
on 10/07/24
165.32 -7.39%
on 11/25/24
+0.11 (+0.07%)
since 09/20/24
52-Week
123.04 +24.43%
on 02/01/24
165.32 -7.39%
on 11/25/24
+18.33 (+13.60%)
since 12/20/23

Most Recent Stories

More News
Stocks Decline Ahead of Wednesday’s FOMC Meeting Results

The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.39%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.61%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.43%. Dec E-mini...

CVS : 44.36 (+1.32%)
AVGO : 220.79 (+1.13%)
PACS : 13.01 (-0.46%)
ADI : 211.78 (+1.93%)
$IUXX : 21,289.15 (+0.85%)
UNH : 500.13 (+2.22%)
PFE : 26.36 (+2.29%)
ZNH25 : 108-310s (+0.33%)
VFC : 22.28 (+2.81%)
FOXA : 49.53 (+1.41%)
TSLA : 421.06 (-3.46%)
ESH25 : 6,001.75s (+1.14%)
Insider Sale: SVP & General Counsel of $DGX (DGX) Sells 3,009 Shares

MICHAEL E PREVOZNIK, the SVP & General Counsel of $DGX ($DGX), sold 3,009 shares of the company on 11-29-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 4.1%...

DGX : 153.10 (+1.04%)
What Are Wall Street Analysts' Target Price for Quest Diagnostics Stock?

Despite Quest Diagnostics’ underperformance relative to the broader S&P 500 Index over the past year, Wall Street analysts remain moderately optimistic about the stock’s prospects.

XLV : 138.00 (+1.26%)
DGX : 153.10 (+1.04%)
$SPX : 5,930.85 (+1.09%)
Alcon Q3 Earnings Top Estimates, Margins Up, Stock Gains in Afterhours

Alcon, Inc. ALC delivered core earnings per share (EPS) of 81 cents for the third quarter of 2024, up 22.7% from the year-ago quarter’s figure (up 25% at the constant exchange rate or CER). The figure...

DGX : 153.10 (+1.04%)
BSX : 88.95 (+0.33%)
RMD : 237.27 (+2.46%)
ALC : 84.76 (+0.69%)
BDX Stock Gains Following Q4 Earnings Beat and Higher Margins

Becton, Dickinson and Company BDX, popularly known as BD, delivered adjusted earnings per share (EPS) of $3.81 in the fourth quarter of fiscal 2024, up 11.4% year over year. The figure topped the Zacks...

DGX : 153.10 (+1.04%)
BSX : 88.95 (+0.33%)
BDX : 227.68 (+1.72%)
RMD : 237.27 (+2.46%)
QIAGEN Stock Flat Post Q3 Earnings & Revenue Beat, 2024 EPS View Up

QIAGEN N.V.’s QGEN third-quarter 2024 adjusted earnings per share (EPS) were 57 cents, 58 cents at the constant exchange rate (CER). The reported figure increased 14% from the 2023 comparable figure...

DGX : 153.10 (+1.04%)
BSX : 88.95 (+0.33%)
QGEN : 44.67 (+0.79%)
ISRG : 524.43 (+0.10%)
CVS Health Q3 Earnings & Revenues Beat, Stock Rises in Premarket

CVS Health Corporation CVS posted adjusted earnings per share (EPS) of $1.09 in the third quarter of 2024, down 50.7% year over year. However, the metric topped the Zacks Consensus Estimate by 1.2%. The...

CVS : 44.36 (+1.32%)
DGX : 153.10 (+1.04%)
BSX : 88.95 (+0.33%)
ISRG : 524.43 (+0.10%)
Catalent's Stock Gains Despite Q1 Earnings Miss, Gross Margin Up

Catalent, Inc. CTLT reported first-quarter fiscal 2025 adjusted loss per share of 13 cents, flat year over year. The figure was wider than the Zacks Consensus Estimate of a loss of 11 cents per share....

DGX : 153.10 (+1.04%)
BSX : 88.95 (+0.33%)
CTLT : 63.48 (unch)
RMD : 237.27 (+2.46%)
Exact Sciences Stock Down on Q3 Earnings & Revenue Miss, '24 View Cut

Exact Sciences Corporation EXAS reported a net loss of 21 cents in third-quarter 2024 compared with break-even earnings in the year-ago quarter. The figure was wider than the Zacks Consensus Estimate...

DGX : 153.10 (+1.04%)
EXAS : 59.40 (+5.86%)
BSX : 88.95 (+0.33%)
ISRG : 524.43 (+0.10%)
Hologic Q4 Earnings Lag, Revenues Top, Stock Down in Aftermarket

Hologic, Inc. HOLX reported adjusted earnings per share (EPS) of $1.01 in the fourth quarter of fiscal 2024, up 13.5% year over year. However, the bottom line missed the Zacks Consensus Estimate by 0.9%.The...

HOLX : 71.65 (+1.26%)
DGX : 153.10 (+1.04%)
BSX : 88.95 (+0.33%)
ISRG : 524.43 (+0.10%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Quest Diagnostics, Inc. is the provider of commercial laboratory services. Quest provides lab testing services to physicians, hospitals, managed care organizations, employers, government institutions and other clinical laboratories. The company consists of 2 business groups - Diagnostic Information Services...

See More

Key Turning Points

3rd Resistance Point 156.66
2nd Resistance Point 155.38
1st Resistance Point 154.24
Last Price 153.10
1st Support Level 151.82
2nd Support Level 150.54
3rd Support Level 149.40

See More

52-Week High 165.32
Last Price 153.10
Fibonacci 61.8% 149.17
Fibonacci 50% 144.18
Fibonacci 38.2% 139.19
52-Week Low 123.04

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar